Arca
Skip to content
Tools
Tools

Cicatrix

Drug research and approvals for cicatrix: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 130 studies of cicatrix are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 130
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 130 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

3 in phase 3, 5 in phase 2, 6 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Onabotulinumtoxina
Phase 3 Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
Urea
Phase 3 Diagnostic agent
Putrescine
Phase 3
AZX-100
Phase 2
Abobotulinumtoxina
Phase 2 Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
Enalaprilat anhydrous
Phase 2 Angiotensin-converting enzyme inhibitor
Pentamidine
Phase 1 DNA inhibitor
Avotermin
Phase 1
Ilodecakin
Phase 1
Lidocaine
Early phase 1 Sodium channel alpha subunit blocker
Racepinephrine
Early phase 1

How Its Trials Ended

260 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 52 whose ending is known, 35% met their primary endpoint, 2% missed it and 63% stopped early.

  • Completed, result not reported12046%
  • Status unknown4919%
  • Ongoing3915%
  • Stopped: other or unclear249%
  • Met its primary endpoint187%
  • Stopped: enrollment or feasibility62%
  • Stopped: lack of efficacy21%
  • Missed its primary endpoint10%
  • Stopped: funding10%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.